Two Phase 3 trials — CREAD 1 and CREAD 2 — evaluating crenezumab as a therapy for early Alzheimer’s disease…
Articles by Patricia Inacio, PhD
Using a new type of approach called epigenetics, researchers were able to temporarily rescue memory and cognitive function in a…
Alzheimer’s disease patients who take anti-epileptic therapies have a higher number of accumulated days spent in the hospital than…
United Neuroscience’s Alzheimer’s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most of the patients, according…
A medicine being developed to treat stroke patients may help protect the brain from Alzheimer’s disease by suppressing the accumulation…
People 60 or older with a disrupted pattern of deep sleep — the one that helps memory formation — have…
Throughout 2018, Alzheimer’s News Today brought you stories of important discoveries, treatment developments, clinical trials, and other events related to Alzheimer’s…
A maternal diet supplemented with choline, an essential nutrient, reduced the number of amyloid plaque deposits and improved memory across two…
A small molecule delivered orally for 56 days improved memory in mice carrying the ApoE4 gene, the most common genetic…
Salt together with acidic conditions can change the 3D structure of the beta2-microglobulin protein and promote the formation of amyloid…